BBlogFlow

Will Reeve of “Good Morning America” Treated for Testicular Cancer - Cancer Health

·4d ago
Source: Cancer Health
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Cancer Health

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Why screen time should be treated as a public health issue: Dr. Peter Lin explains - CBC

Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchradioTop StoriesShowsPodcastsSchedulesFrequencyListen LiveVideoWhy screen time should be treated as a public health issue: Dr. Peter Lin explains | CBC.ca LoadedThe Morning Edition - K-W7:49Why screen time should be treated as a public health issue: Dr. Peter Lin explainsOctober 8RadioDuration 7:49Dopamine on demand. Dr. Peter Lin explains how tech companies exploit our brain chemistry, and discusses a new study that calls for government action. More from RadioVideoDuration 1:18‘She’s trying to change the culture of Cornell,’ says Jane Doe’s lawyerOctober 14VideoDuration 1:04Jane Doe’s home was swatted, says lawyer in Cornell gang-rape caseOctober 14VideoDuration 1:40How menopause shook Olympian Clara HughesOctober 12VideoDuration 1:53Will Carney's plan to 'Build Canada Strong' hurt the environment?

CBC·

Tech analyst Carmi Levy on Lancet study saying social media must be treated as public health concern - CBC

Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesDisability LifeGo PublicAbout CBC NewsBeing Black in CanadaVideoTech analyst Carmi Levy on Lancet study saying social media must be treated as public health concern | CBC.ca LoadedTech analyst Carmi Levy on Lancet study saying social media must be treated as public health concernOctober 4|Duration 8:13October 4NewsDuration 8:13closed captionGet the latest on CBCNews.ca, the CBC News App, and CBC News Network for breaking news and analysis. Related StoriesNaomi Klein on Carney, trade war and 'end times' - TranscriptIs AI inevitable?

CBC·

Virtual Course Launch: Clubfoot can be treated: A course for healthcare workers - Pan American Health Organization (PAHO)

Join us on Friday, October 30, at 10:00 a.m. (Washington, D. C. time) for the "Virtual Course Launch: Clubfoot can be treated: A course for healthcare workers". BackgroundClubfoot is one of the most common congenital musculoskeletal disorders and is a preventable cause of disability when not identified and treated in a timely manner. However, through early detection, appropriate referral and access to appropriate treatment, it is possible to achieve favorable functional outcomes and avoid the consequences associated with lack of treatment. In this context, the training of health workers plays a key role. Timely recognition of clubfoot from birth, appropriate guidance to families, and early referral to trained services for its treatment are essential components for improving access to and outcomes of care. In 2023, the Pan American Health Organization (PAHO), in conjunction with MiracleFeet, launched the virtual course "Clubfoot is treatable: a course for Health Workers", available through PAHO's Virtual Campus of Public Health. The initiative sought to strengthen the knowledge of health teams and promote the timely detection and referral of children with clubfoot.

Pan American Health Organization (PAHO)·

Bioengineer.org | Switching HIV drugs or adding zoledronic acid rebuilds bone lost to tenofovir - European AIDS Treatment Group

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.

European AIDS Treatment Group·